SEC 13F Intelligence

Glenmede Trust Co Na / AMGN

Glenmede Trust Co Na’s Amgen Inc Position

Does Glenmede Trust Co Na own Amgen Inc (AMGN)? Yes — 127.2K shares worth $45M (+0.22% of its 13F portfolio) as of Q1 2026, down from 128.5K shares the prior filed quarter.

Position Value
$45M
Q1 2026
Shares
127.2K
% of Portfolio
+0.22%
Quarters Held
28
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $159MQ4 ’18Q1 ’19: $155MQ2 ’19: $152MQ3 ’19: $153MQ4 ’19: $191MQ4 ’19Q1 ’20: $191MQ2 ’20: $144MQ3 ’20: $148MQ4 ’20: $134MQ4 ’20Q1 ’21: $127MQ2 ’21: $107MQ3 ’21: $93MQ4 ’21: $101MQ4 ’21Q1 ’22: $100MQ2 ’22: $94MQ3 ’22: $88MQ4 ’22: $95MQ4 ’22Q1 ’23: $87MQ2 ’23: $87MQ3 ’23: $95MQ4 ’23: $90MQ4 ’23Q1 ’24: $84MQ2 ’24: $73MQ3 ’24: $61MQ4 ’24: $31MQ4 ’24Q1 ’25: $36MQ4 ’25: $42MQ1 ’26: $45Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026127.2K$45M+0.22%
Q4 2025128.5K$42M+0.20%
Q1 2025115.9K$36M+0.19%
Q4 2024118.5K$31M+0.16%
Q3 2024190.4K$61M+0.29%
Q2 2024232.9K$73M+0.37%
Q1 2024295.3K$84M+0.42%
Q4 2023312.4K$90M+0.47%
Q3 2023353.8K$95M+0.54%
Q2 2023359.3K$87M+0.49%
Q1 2023359.4K$87M+0.49%
Q4 2022360.7K$95M+0.56%
Q3 2022392.5K$88M+0.56%
Q2 2022385.4K$94M+0.55%
Q1 2022413.1K$100M+0.49%
Q4 2021447.7K$101M+0.48%
Q3 2021438.1K$93M+0.48%
Q2 2021437.1K$107M+0.55%
Q1 2021510.4K$127M+0.68%
Q4 2020583.2K$134M+0.74%
Q3 2020582.9K$148M+0.89%
Q2 2020610.2K$144M+0.88%
Q1 2020790.7K$191M+0.87%
Q4 2019790.7K$191M+0.87%
Q3 2019792.4K$153M+0.70%
Q2 2019824.7K$152M+0.67%
Q1 2019815.0K$155M+0.70%
Q4 2018817.1K$159M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenmede Trust Co Na’s full portfolio or all institutional holders of AMGN.